CLASS data FOR NOVEL APPROACH TO CANCER treatment. Parsortix system used to identify patients with highly metastatic C ...

The publication reports on an interventional multi-centre Phase 1 clinical trial using the repurposed, FDA approved drug, digoxin, to treat metastatic breast cancer patients. The Parsortix ...